APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antiretroviral Therapy

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antiretroviral Therapy Industry Growth and Trends Forecast to 2032

27 December 202599 pages

Choose your research edition.

Industry ResearchAntiretroviral Therapy Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiretroviral Therapy Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Antiretroviral Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiretroviral Therapy Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiretroviral Therapy Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Antiretroviral Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antiretroviral Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antiretroviral Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiretroviral Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiretroviral Therapy include Janssen Pharmaceuticals, Mylan, Abbvie, ViiV Healthcare, Vertex Pharmaceuticals, Gilead, F. Hoffmann-La Roche, Boehringer Ingelheim and Bionor Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antiretroviral Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antiretroviral Therapy market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antiretroviral Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antiretroviral Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antiretroviral Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antiretroviral Therapy Market by Company

Janssen Pharmaceuticals

Mylan

Abbvie

ViiV Healthcare

Vertex Pharmaceuticals

Gilead

F. Hoffmann-La Roche

Boehringer Ingelheim

Bionor Pharma

Antiretroviral Therapy Segment by Type

Integrase Inhibitors

NRTI

NNRTIs

Multiclass Combination Products

Antiretroviral Therapy Segment by Application

Hospital

Clinic

Other

Antiretroviral Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiretroviral Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiretroviral Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiretroviral Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antiretroviral Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antiretroviral Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Integrase Inhibitors Table 2. Major Company of NRTI Table 3. Major Company of NNRTIs Table 4. Major Company of Multiclass Combination Products Table 5. Global Antiretroviral Therapy Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Antiretroviral Therapy Sales by Type (2021-2026) & (Kg) Table 7. Global Antiretroviral Therapy Sales Market Share in Volume by Type (2021-2026) Table 8. Global Antiretroviral Therapy Sales by Type (2021-2026) & (US$ Million) Table 9. Global Antiretroviral Therapy Sales Market Share in Value by Type (2021-2026) Table 10. Global Antiretroviral Therapy Price by Type (2021-2026) & (US$/Kg) Table 11. Global Antiretroviral Therapy Sales by Type (2027-2032) & (Kg) Table 12. Global Antiretroviral Therapy Sales Market Share in Volume by Type (2027-2032) Table 13. Global Antiretroviral Therapy Sales by Type (2027-2032) & (US$ Million) Table 14. Global Antiretroviral Therapy Sales Market Share in Value by Type (2027-2032) Table 15. Global Antiretroviral Therapy Price by Type (2027-2032) & (US$/Kg) Table 16. North America Antiretroviral Therapy Sales by Type (2021-2026) & (Kg) Table 17. North America Antiretroviral Therapy Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Antiretroviral Therapy Sales by Type (2021-2026) & (Kg) Table 19. Europe Antiretroviral Therapy Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Antiretroviral Therapy Sales by Type (2021-2026) & (Kg) Table 21. Asia-Pacific Antiretroviral Therapy Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Antiretroviral Therapy Sales by Type (2021-2026) & (Kg) Table 23. Latin America Antiretroviral Therapy Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Antiretroviral Therapy Sales by Type (2021-2026) & (Kg) Table 25. Middle East and Africa Antiretroviral Therapy Sales by Type (2021-2026) & (US$ Million) Table 26. Antiretroviral Therapy Industry Trends Table 27. Antiretroviral Therapy Industry Drivers Table 28. Antiretroviral Therapy Industry Opportunities and Challenges Table 29. Antiretroviral Therapy Industry Restraints Table 30. Global Antiretroviral Therapy Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Antiretroviral Therapy Revenue Market Share by Company (2021-2026) Table 32. Global Antiretroviral Therapy Sales by Company (2021-2026) & (Kg) Table 33. Global Antiretroviral Therapy Sales Share by Company (2021-2026) Table 34. Global Antiretroviral Therapy Market Price by Company (2021-2026) & (US$/Kg) Table 35. Global Antiretroviral Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Antiretroviral Therapy Major Company Production Sites and Headquarters Table 37. Global Antiretroviral Therapy Company, Product Type & Application Table 38. Global Antiretroviral Therapy Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Antiretroviral Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Antiretroviral Therapy Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Antiretroviral Therapy Sales by Region (2021-2026) & (Kg) Table 43. Global Antiretroviral Therapy Sales Market Share in Volume by Region (2021-2026) Table 44. Global Antiretroviral Therapy Sales by Region (2021-2026) & (US$ Million) Table 45. Global Antiretroviral Therapy Sales Market Share in Value by Region (2021-2026) Table 46. Global Antiretroviral Therapy Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 47. Global Antiretroviral Therapy Sales by Region (2027-2032) & (Kg) Table 48. Global Antiretroviral Therapy Sales Market Share in Volume by Region (2027-2032) Table 49. Global Antiretroviral Therapy Sales by Region (2027-2032) & (US$ Million) Table 50. Global Antiretroviral Therapy Sales Market Share in Value by Region (2027-2032) Table 51. Global Antiretroviral Therapy Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 52. Global Antiretroviral Therapy Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Antiretroviral Therapy Sales by Application (2021-2026) & (Kg) Table 54. Global Antiretroviral Therapy Sales Market Share in Volume by Application (2021-2026) Table 55. Global Antiretroviral Therapy Sales by Application (2021-2026) & (US$ Million) Table 56. Global Antiretroviral Therapy Sales Market Share in Value by Application (2021-2026) Table 57. Global Antiretroviral Therapy Price by Application (2021-2026) & (US$/Kg) Table 58. Global Antiretroviral Therapy Sales by Application (2027-2032) & (Kg) Table 59. Global Antiretroviral Therapy Sales Market Share in Volume by Application (2027-2032) Table 60. Global Antiretroviral Therapy Sales by Application (2027-2032) & (US$ Million) Table 61. Global Antiretroviral Therapy Sales Market Share in Value by Application (2027-2032) Table 62. Global Antiretroviral Therapy Price by Application (2027-2032) & (US$/Kg) Table 63. North America Antiretroviral Therapy Sales by Application (2021-2026) & (Kg) Table 64. North America Antiretroviral Therapy Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Antiretroviral Therapy Sales by Application (2021-2026) & (Kg) Table 66. Europe Antiretroviral Therapy Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Antiretroviral Therapy Sales by Application (2021-2026) & (Kg) Table 68. Asia-Pacific Antiretroviral Therapy Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Antiretroviral Therapy Sales by Application (2021-2026) & (Kg) Table 70. Latin America Antiretroviral Therapy Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Antiretroviral Therapy Sales by Application (2021-2026) & (Kg) Table 72. Middle East and Africa Antiretroviral Therapy Sales by Application (2021-2026) & (US$ Million) Table 73. Janssen Pharmaceuticals Company Information Table 74. Janssen Pharmaceuticals Business Overview Table 75. Janssen Pharmaceuticals Antiretroviral Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Janssen Pharmaceuticals Antiretroviral Therapy Product Portfolio Table 77. Janssen Pharmaceuticals Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Antiretroviral Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Mylan Antiretroviral Therapy Product Portfolio Table 82. Mylan Recent Development Table 83. Abbvie Company Information Table 84. Abbvie Business Overview Table 85. Abbvie Antiretroviral Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Abbvie Antiretroviral Therapy Product Portfolio Table 87. Abbvie Recent Development Table 88. ViiV Healthcare Company Information Table 89. ViiV Healthcare Business Overview Table 90. ViiV Healthcare Antiretroviral Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. ViiV Healthcare Antiretroviral Therapy Product Portfolio Table 92. ViiV Healthcare Recent Development Table 93. Vertex Pharmaceuticals Company Information Table 94. Vertex Pharmaceuticals Business Overview Table 95. Vertex Pharmaceuticals Antiretroviral Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Vertex Pharmaceuticals Antiretroviral Therapy Product Portfolio Table 97. Vertex Pharmaceuticals Recent Development Table 98. Gilead Company Information Table 99. Gilead Business Overview Table 100. Gilead Antiretroviral Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Gilead Antiretroviral Therapy Product Portfolio Table 102. Gilead Recent Development Table 103. F. Hoffmann-La Roche Company Information Table 104. F. Hoffmann-La Roche Business Overview Table 105. F. Hoffmann-La Roche Antiretroviral Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. F. Hoffmann-La Roche Antiretroviral Therapy Product Portfolio Table 107. F. Hoffmann-La Roche Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim Antiretroviral Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim Antiretroviral Therapy Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Bionor Pharma Company Information Table 114. Bionor Pharma Business Overview Table 115. Bionor Pharma Antiretroviral Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. Bionor Pharma Antiretroviral Therapy Product Portfolio Table 117. Bionor Pharma Recent Development Table 118. North America Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 119. North America Antiretroviral Therapy Sales by Country (2021-2026) & (Kg) Table 120. North America Antiretroviral Therapy Sales Market Share by Country (2021-2026) Table 121. North America Antiretroviral Therapy Sales Forecast by Country (2027-2032) & (Kg) Table 122. North America Antiretroviral Therapy Sales Market Share Forecast by Country (2027-2032) Table 123. North America Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Antiretroviral Therapy Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Antiretroviral Therapy Market Share by Country (2021-2026) Table 126. North America Antiretroviral Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Antiretroviral Therapy Market Share Forecast by Country (2027-2032) Table 128. Europe Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 129. Europe Antiretroviral Therapy Sales by Country (2021-2026) & (Kg) Table 130. Europe Antiretroviral Therapy Sales Market Share by Country (2021-2026) Table 131. Europe Antiretroviral Therapy Sales Forecast by Country (2027-2032) & (Kg) Table 132. Europe Antiretroviral Therapy Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Antiretroviral Therapy Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Antiretroviral Therapy Market Share by Country (2021-2026) Table 136. Europe Antiretroviral Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Antiretroviral Therapy Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Antiretroviral Therapy Sales by Country (2021-2026) & (Kg) Table 140. Asia-Pacific Antiretroviral Therapy Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Antiretroviral Therapy Sales Forecast by Country (2027-2032) & (Kg) Table 142. Asia-Pacific Antiretroviral Therapy Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Antiretroviral Therapy Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Antiretroviral Therapy Market Share by Country (2021-2026) Table 146. Asia-Pacific Antiretroviral Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Antiretroviral Therapy Market Share Forecast by Country (2027-2032) Table 148. Latin America Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 149. Latin America Antiretroviral Therapy Sales by Country (2021-2026) & (Kg) Table 150. Latin America Antiretroviral Therapy Sales Market Share by Country (2021-2026) Table 151. Latin America Antiretroviral Therapy Sales Forecast by Country (2027-2032) & (Kg) Table 152. Latin America Antiretroviral Therapy Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Antiretroviral Therapy Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Antiretroviral Therapy Market Share by Country (2021-2026) Table 156. Latin America Antiretroviral Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Antiretroviral Therapy Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Antiretroviral Therapy Sales by Country (2021-2026) & (Kg) Table 160. Middle East and Africa Antiretroviral Therapy Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Antiretroviral Therapy Sales Forecast by Country (2027-2032) & (Kg) Table 162. Middle East and Africa Antiretroviral Therapy Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Antiretroviral Therapy Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Antiretroviral Therapy Market Share by Country (2021-2026) Table 166. Middle East and Africa Antiretroviral Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Antiretroviral Therapy Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Antiretroviral Therapy Distributors List Table 171. Antiretroviral Therapy Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Antiretroviral Therapy Image Figure 2. Global Antiretroviral Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiretroviral Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Antiretroviral Therapy Sales (2021-2032) & (Kg) Figure 5. Integrase Inhibitors Image Figure 6. Global Integrase Inhibitors Sales YoY Growth (2021-2032) & (Kg) Figure 7. NRTI Image Figure 8. Global NRTI Sales YoY Growth (2021-2032) & (Kg) Figure 9. NNRTIs Image Figure 10. Global NNRTIs Sales YoY Growth (2021-2032) & (Kg) Figure 11. Multiclass Combination Products Image Figure 12. Global Multiclass Combination Products Sales YoY Growth (2021-2032) & (Kg) Figure 13. Global Antiretroviral Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Antiretroviral Therapy Market Share by Type 2025 VS 2032 Figure 15. North America Antiretroviral Therapy Sales Market Share in Volume by Type in 2025 Figure 16. North America Antiretroviral Therapy Sales Market Share in Value by Type in 2025 Figure 17. Europe Antiretroviral Therapy Sales Market Share in Volume by Type in 2025 Figure 18. Europe Antiretroviral Therapy Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Antiretroviral Therapy Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Antiretroviral Therapy Sales Market Share in Value by Type in 2025 Figure 21. Latin America Antiretroviral Therapy Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Antiretroviral Therapy Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Antiretroviral Therapy Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Antiretroviral Therapy Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Antiretroviral Therapy Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (Kg) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (Kg) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (Kg) Figure 33. Global Antiretroviral Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Antiretroviral Therapy Market Share by Application 2025 VS 2032 Figure 35. North America Antiretroviral Therapy Sales Market Share in Volume by Application in 2025 Figure 36. North America Antiretroviral Therapy Sales Market Share in Value by Application in 2025 Figure 37. Europe Antiretroviral Therapy Sales Market Share in Volume by Application in 2025 Figure 38. Europe Antiretroviral Therapy Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Antiretroviral Therapy Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Antiretroviral Therapy Sales Market Share in Value by Application in 2025 Figure 41. Latin America Antiretroviral Therapy Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Antiretroviral Therapy Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Antiretroviral Therapy Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Antiretroviral Therapy Sales Market Share in Value by Application in 2025 Figure 45. North America Antiretroviral Therapy Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 46. North America Antiretroviral Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Antiretroviral Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Antiretroviral Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Antiretroviral Therapy Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 50. Europe Antiretroviral Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Antiretroviral Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Antiretroviral Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Antiretroviral Therapy Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 54. Asia-Pacific Antiretroviral Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Antiretroviral Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Antiretroviral Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Antiretroviral Therapy Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 58. Latin America Antiretroviral Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Antiretroviral Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Antiretroviral Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Antiretroviral Therapy Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 62. Middle East and Africa Antiretroviral Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Antiretroviral Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Antiretroviral Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Antiretroviral Therapy Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Antiretroviral Therapy Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Integrase Inhibitors
  • NRTI
  • NNRTIs
  • Multiclass Combination Products
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Janssen Pharmaceuticals
  • Mylan
  • Abbvie
  • ViiV Healthcare
  • Vertex Pharmaceuticals
  • Gilead
  • F. Hoffmann-La Roche
  • Boehringer Ingelheim
  • Bionor Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antiretroviral Therapy Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antiretroviral Therapy Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antiretroviral Therapy Market by Type
  6. 1.3.1 Integrase Inhibitors
  7. 1.3.2 NRTI
  8. 1.3.3 NNRTIs
  9. 1.3.4 Multiclass Combination Products
  10. 1.4 Global Antiretroviral Therapy Market Size by Type
  11. 1.4.1 Global Antiretroviral Therapy Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Antiretroviral Therapy Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Antiretroviral Therapy Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Antiretroviral Therapy Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Antiretroviral Therapy Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Antiretroviral Therapy Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Antiretroviral Therapy Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Antiretroviral Therapy Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antiretroviral Therapy Industry Trends
  2. 2.2 Antiretroviral Therapy Industry Drivers
  3. 2.3 Antiretroviral Therapy Industry Opportunities and Challenges
  4. 2.4 Antiretroviral Therapy Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antiretroviral Therapy Revenue (2021-2026)
  2. 3.2 Global Top Players by Antiretroviral Therapy Sales (2021-2026)
  3. 3.3 Global Top Players by Antiretroviral Therapy Price (2021-2026)
  4. 3.4 Global Antiretroviral Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antiretroviral Therapy Major Company Production Sites & Headquarters
  6. 3.6 Global Antiretroviral Therapy Company, Product Type & Application
  7. 3.7 Global Antiretroviral Therapy Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antiretroviral Therapy Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antiretroviral Therapy Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antiretroviral Therapy Tier 1, Tier 2, and Tier 3
4 Antiretroviral Therapy Regional Status and Outlook
  1. 4.1 Global Antiretroviral Therapy Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antiretroviral Therapy Historic Market Size by Region
  3. 4.2.1 Global Antiretroviral Therapy Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antiretroviral Therapy Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antiretroviral Therapy Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antiretroviral Therapy Forecasted Market Size by Region
  7. 4.3.1 Global Antiretroviral Therapy Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antiretroviral Therapy Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antiretroviral Therapy Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antiretroviral Therapy by Application
  1. 5.1 Antiretroviral Therapy Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Antiretroviral Therapy Market Size by Application
  6. 5.2.1 Global Antiretroviral Therapy Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antiretroviral Therapy Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antiretroviral Therapy Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antiretroviral Therapy Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antiretroviral Therapy Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antiretroviral Therapy Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antiretroviral Therapy Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antiretroviral Therapy Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Janssen Pharmaceuticals
  2. 6.1.1 Janssen Pharmaceuticals Company Information
  3. 6.1.2 Janssen Pharmaceuticals Business Overview
  4. 6.1.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Janssen Pharmaceuticals Antiretroviral Therapy Product Portfolio
  6. 6.1.5 Janssen Pharmaceuticals Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Antiretroviral Therapy Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 Abbvie
  14. 6.3.1 Abbvie Company Information
  15. 6.3.2 Abbvie Business Overview
  16. 6.3.3 Abbvie Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Abbvie Antiretroviral Therapy Product Portfolio
  18. 6.3.5 Abbvie Recent Developments
  19. 6.4 ViiV Healthcare
  20. 6.4.1 ViiV Healthcare Company Information
  21. 6.4.2 ViiV Healthcare Business Overview
  22. 6.4.3 ViiV Healthcare Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 ViiV Healthcare Antiretroviral Therapy Product Portfolio
  24. 6.4.5 ViiV Healthcare Recent Developments
  25. 6.5 Vertex Pharmaceuticals
  26. 6.5.1 Vertex Pharmaceuticals Company Information
  27. 6.5.2 Vertex Pharmaceuticals Business Overview
  28. 6.5.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vertex Pharmaceuticals Antiretroviral Therapy Product Portfolio
  30. 6.5.5 Vertex Pharmaceuticals Recent Developments
  31. 6.6 Gilead
  32. 6.6.1 Gilead Company Information
  33. 6.6.2 Gilead Business Overview
  34. 6.6.3 Gilead Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Gilead Antiretroviral Therapy Product Portfolio
  36. 6.6.5 Gilead Recent Developments
  37. 6.7 F. Hoffmann-La Roche
  38. 6.7.1 F. Hoffmann-La Roche Company Information
  39. 6.7.2 F. Hoffmann-La Roche Business Overview
  40. 6.7.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 F. Hoffmann-La Roche Antiretroviral Therapy Product Portfolio
  42. 6.7.5 F. Hoffmann-La Roche Recent Developments
  43. 6.8 Boehringer Ingelheim
  44. 6.8.1 Boehringer Ingelheim Company Information
  45. 6.8.2 Boehringer Ingelheim Business Overview
  46. 6.8.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Boehringer Ingelheim Antiretroviral Therapy Product Portfolio
  48. 6.8.5 Boehringer Ingelheim Recent Developments
  49. 6.9 Bionor Pharma
  50. 6.9.1 Bionor Pharma Company Information
  51. 6.9.2 Bionor Pharma Business Overview
  52. 6.9.3 Bionor Pharma Antiretroviral Therapy Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bionor Pharma Antiretroviral Therapy Product Portfolio
  54. 6.9.5 Bionor Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Antiretroviral Therapy Sales by Country
  2. 7.1.1 North America Antiretroviral Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antiretroviral Therapy Sales by Country (2021-2026)
  4. 7.1.3 North America Antiretroviral Therapy Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antiretroviral Therapy Market Size by Country
  6. 7.2.1 North America Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antiretroviral Therapy Market Size by Country (2021-2026)
  8. 7.2.3 North America Antiretroviral Therapy Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antiretroviral Therapy Sales by Country
  2. 8.1.1 Europe Antiretroviral Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antiretroviral Therapy Sales by Country (2021-2026)
  4. 8.1.3 Europe Antiretroviral Therapy Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antiretroviral Therapy Market Size by Country
  6. 8.2.1 Europe Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antiretroviral Therapy Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antiretroviral Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antiretroviral Therapy Sales by Country
  2. 9.1.1 Asia-Pacific Antiretroviral Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antiretroviral Therapy Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antiretroviral Therapy Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antiretroviral Therapy Market Size by Country
  6. 9.2.1 Asia-Pacific Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antiretroviral Therapy Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antiretroviral Therapy Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antiretroviral Therapy Sales by Country
  2. 10.1.1 South America Antiretroviral Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antiretroviral Therapy Sales by Country (2021-2026)
  4. 10.1.3 South America Antiretroviral Therapy Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antiretroviral Therapy Market Size by Country
  6. 10.2.1 South America Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antiretroviral Therapy Market Size by Country (2021-2026)
  8. 10.2.3 South America Antiretroviral Therapy Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antiretroviral Therapy Sales by Country
  2. 11.1.1 Middle East and Africa Antiretroviral Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antiretroviral Therapy Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antiretroviral Therapy Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antiretroviral Therapy Market Size by Country
  6. 11.2.1 Middle East and Africa Antiretroviral Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antiretroviral Therapy Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antiretroviral Therapy Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antiretroviral Therapy Value Chain Analysis
  2. 12.1.1 Antiretroviral Therapy Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antiretroviral Therapy Production Mode & Process
  7. 12.2 Antiretroviral Therapy Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antiretroviral Therapy Distributors
  10. 12.2.3 Antiretroviral Therapy Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst